Trial intelligence / Profile preview

Levamisole as an adjuvant to hepatitis B vaccination in patients with HIV/AIDS

IRCT201207275349N2Phase 4Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Apr 2008
Modality
Small Molecules, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial in hepatitis B (HBV) comparing Levamisole plus hepatitis B vaccine with Control hepatitis B vaccine (2 arms). Started Apr 2008; status: completed.

02

Drugs

levamisoleHepatitis B vaccine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on IRCT201207275349N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201207275349N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call